当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2018年第9期
编号:13278724
HEV vaccine in China(5)
http://www.100md.com 2018年9月1日 《特别健康·下半月》 2018年第9期
     W.Huang,H.Zhang,Tim J.Harrison et al.(2008).Cross-Protection of Hepatitis E Virus Genotypes 1 and 4 in Rhesus Macaques.Journal of Medical Virology.80 (0),824–832.

    Xin Yin,Xinlei Li,Zongdi Feng.(2016).Role of Envelopment in the HEV Life Cycle.Viruses.8 (8),229.

    Yamada K,Takahashi M,Hoshino Y et al.(2009) Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cells.Journalof General Virology; 90: 457–462.

    Zhao Q,Zhang J,Wu T,et al.(2013) Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.J Gas- troenterol;48:159–68.

    Zhu,F.C.,Zhang,J.,Zhang,X.F.,Zhou,et al.(2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale,randomised,double-blind placebo-controlled,phase 3 trial.Lancet 376,895–902

    Z.Tanga,M.Tangb,Min Zhao.(2015).A novel linear neutralizing epitope of hepatitis E virus.Vaccine.33,3504–3511., 百拇医药(DongNa MouJingyi AlexanderPloss)
上一页1 2 3 4 5